Five-factor prognostic model for survival of post-platinum patients with metastatic urothelial carcinoma receiving PD-L1 inhibitors

PURPOSE: A prognostic model for overall survival (OS) of post-platinum patients with metastatic urothelial carcinoma (mUC) receiving PD-1/PD-L1 inhibitors is necessary since existing models were constructed in the chemotherapy setting. MATERIALS AND METHODS: Patient level data were used from phase I...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Urol
Main Authors: Sonpavde, Guru, Manitz, Juliane, Gao, Chen, Tayama, Darren, Kaiser, Constanze, Hennessy, Daniel, Makari, Doris, Gupta, Ashok, Abdullah, Shaad Essa, Niegisch, Guenter, Rosenberg, Jonathan E., Bajorin, Dean F., Grivas, Petros, Apolo, Andrea B., Dreicer, Robert, Hahn, Noah M., Galsky, Matthew D., Necchi, Andrea, Srinivas, Sandy, Powles, Thomas, Choueiri, Toni K., Pond, Gregory R.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655635/
https://ncbi.nlm.nih.gov/pubmed/32552295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000001199
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki